Oncolytics Biotech Inc.

ONCY · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$14-$6-$7-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$1$1$1
Change in WC$3-$0-$1-$1
Other Non-Cash$1$0-$0-$0
Operating Cash Flow-$7-$5-$6-$8
Investing Activities
PP&E Inv.-$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$4$5$6$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$4$5$6$3
Forex Effect$0-$1-$0$1
Net Chg. in Cash-$2-$1-$1-$4
Supplemental Information
Beg. Cash$15$15$16$20
End Cash$12$15$15$16
Free Cash Flow-$7-$5-$6-$8
Oncolytics Biotech Inc. (ONCY) Financial Statements & Key Stats | AlphaPilot